MEDIASTINAL WIDENING WITH ISOLATED BULBAR WEAKNESS- A MASQUERADE OF MYASTHENIA GRAVIS
Abstract
per year. Thymoma is usually a begin tumour from anterior mediastinum. About one third of cases
were diagnosed during Myasthenia Gravis evaluation. One third as asymptomatic mass, one third as
obstructive features. Myasthenia Gravis is the common para-neoplastic syndrome associated with
Thymoma. Ocular weakness is most typical and usual presentation with or without limb involvement,
while early or isolated oropharngeal or limb weakness is very rare. Mainstay of treatment of
Thymoma with Myasthenia Gravis is surgical resection with adequate preoperative preparations such
as plasmapheresis or IV Immunoglobulin.
Full Text:
PDFReferences
Engels EA. Epidemiology of thymoma and associated malignancies. J Thorac Oncol
;5:S260-5
Inoue M1, Kojima Y, Kinboshi M, Nakagawa T, Kanda M, Shibasaki H., A case of myasthenia
gravis presenting solely with bulbar palsy unassociated with easy fatigability, Rinsho Shinkeigaku.
;53(3):229-34.
Detterbeck FC, Parsons AM. Management of stage I and II thymoma. Thorac Surg Clin
;21:59-67.
Venuta F, Rendina EA, Longo F, et al. Long-term outcome after multimodality treatment for
stage III thymic tumors. Ann Thorac Surg 2003;76:1866-72.
Lewis JE, Wick MR, Scheithauer BW, et al. Thymoma. A clinicopathologic review. Cancer
;60:2727-43.
Detterbeck FC, Moran C, Huang J, et al. Which way is up? Policies and procedures for
surgeons and pathologists regarding resection specimens of thymic malignancy. J Thorac Oncol
;6:S1730-8.
Marom EM. Imaging thymoma. J Thorac Oncol 2010;5:S296-303.
Yamakawa Y, Masaoka A, Hashimoto T, et al. A tentative tumor-node-metastasis classification
of thymoma. Cancer 1991;68:1984-7.
Pescarmona E, Rendina EA, Venuta F, et al. The prognostic implication of thymoma histologic
subtyping. A study of 80 consecutive cases. Am J Clin Pathol 1990;93:190-5.
Nakagawa K, Asamura H, Matsuno Y, et al. Thymoma: a clinicopathologic study based on the
new World Health Organization classification. J Thorac Cardiovasc Surg 2003;126:1134-40.
Okumura M, Ohta M, Tateyama H, et al. The World Health Organization histologic classification
system reflects the oncologic behavior of thymoma: a clinical study of 273 patients. Cancer
;94:624-32.
Okumura M, Shiono H, Inoue M, et al. Outcome of surgical treatment for recurrent thymic
epithelial tumors with reference to world health organization histologic classification system. J Surg
Oncol 2007;95:40-4.
Utsumi T, Shiono H, Kadota Y, et al. Postoperative radiation therapy after complete resection of
thymoma has little impact on survival. Cancer 2009;115:5413-20.
Kondo K. Optimal therapy for thymoma. J Med Invest 2008;55:17-28.
Korst RJ, Kansler AL, Christos PJ, et al. Adjuvant radiotherapy for thymic epithelial tumors: a
systematic review and meta-analysis. Ann Thorac Surg 2009;87:1641-7.
Venuta F, Anile M, Rendina EA, et al. The value of transcapsular invasion in patients with
thymoma. Arch Pathol Lab Med 2009;133:1364-5.
Maggi G, Casadio C, Ardissone F, et al. Thymoma: results of 241 operated cases. Acta
Otorhinolaryngol Ital 1990; 10:109.
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
An initiative of The Tamil Nadu Dr M.G.R. Medical University